Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Qingdao Restore Biotechnology Co. Ltd. operates in the Biotechnology & Pharmaceuticals technology area. The company's patent portfolio currently features 1 pending office action that must be addressed. This active file is being reviewed by 1 distinct examiner, which simplifies the communication process between the patent office and the applicant. The prosecution is also limited to 1 distinct art unit, suggesting that the underlying technology is categorized within a specific pharmaceutical or biological niche.
The busiest examiner for this portfolio is LEE, HOI YAN NMN, who is currently managing 1 busiest examiner pending office action. As the total count of pending office actions is 1, this examiner's review will determine the immediate success of the company's patenting efforts. Practitioners should focus on the specific examination style of LEE, HOI YAN NMN within the Biotechnology & Pharmaceuticals sector. The presence of 1 distinct examiner and 1 distinct art unit indicates that the company does not currently face the complexity of managing disparate examiner expectations across different technical units.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §112 only | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| LEE, HOI YAN NMN | 1 | 38.2% | +76.6% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18377942 | RECRYSTALLIZATION METHOD FOR NMN PREPARATION | LEE, HOI YAN NMN | 33d |
| Art Unit | Apps |
|---|---|
| 1693 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18377942 | RECRYSTALLIZATION METHOD FOR NMN PREPARATION | LEE, HOI YAN NMN | 1693 | §112 | Non-Final OA | 33d | Pending | Oct 09, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialQingdao Restore Biotechnology Co. Ltd. has 1 pending office actions as of November 2026, spread across 1 art units and 1 examiners.
Hoi Yan Nmn Lee has the most, with 1 of Qingdao Restore Biotechnology Co. Ltd.'s pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.